Cited by 463Drug Transport and Resistance MechanismsBarrier Structure and Function StudiesAmino Acid Enzymes and Metabolism

The DOI matches its Crossref record.

Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids

Oldendorf, WH·1973·American Journal of Physiology-Legacy Content

DOI 10.1152/ajplegacy.1973.224.6.1450

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1152/ajplegacy.1973.224.6.1450

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 301–400 of 461

Medium-chain triglycerides may improve memory in non-demented older adults: a systematic review of randomized controlled trials
Giannos, P., Prokopidis, K., Lidoriki, I., Triantafyllidis, K. K., Kechagias, K. S., Celoch, K., Candow, D. G., Ostojić, S. M., & Forbes, S. C. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03521-6 · Cited by 14
“Both C8 and C10 can cross the blood brain barrier [34, 35].”
Background
Treatment of Essential Tremor with Long-Chain Alcohols: Still Experimental or Ready for Prime Time?
Haubenberger, D., Nahab, F. B., Voller, B., & Hallett, M. (2013) · Europe PMC (PubMed Central) · doi:10.7916/d82r3ppm · Cited by 15
Monographs on fragrance raw materials
Opdyke, D. L. J. (1981) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(81)90311-4 · Cited by 14
Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems
Tsuji, A. (2005) · Neurotherapeutics · doi:10.1007/bf03206642 · Cited by 14
Octanoic Acid Produces Accumulation of Monoamine Acidic Metabolites in the Brain: Interaction with Organic Anion Transport at the Choroid Plexus
Kim, T. S., Roe, C. R., Mann, J. D., & Breese, G. R. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11370.x · Cited by 13
Mechanism of valproic acid uptake by isolated rat brain microvessels
Naora, K., & Shen, D. D. (1995) · Epilepsy Research · doi:10.1016/0920-1211(95)00034-8 · Cited by 14
“Oldendorf [26] provided the first evidence for a carrier-mediated transport of short-chain (C2-C5) fatty acids and lactic acid at the blood-brain barrier.”
Background
Synthesis and preliminary evaluation of [1-11C]hexanoate as a PET tracer of fatty acid metabolism
Ishiwata, K., Ishii, K., Ogawa, K., et al. (1995) · Annals of Nuclear Medicine · doi:10.1007/bf03165010 · Cited by 14
Ocular Circulation
Riva, C. E., Alm, A., & Pournaras, C. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-05714-1.00010-8 · Cited by 20
Inhibition of Rat Brain Lipid Synthesis In Vitro by 4-Hydroxybutyric Acid
Silva, A. R., Ruschel, C. F. C., Helegda, C., et al. (1999) · Metabolic Brain Disease · doi:10.1023/a:1020658624567 · Cited by 13
“4HB, like acetate, is a monocarboxylic acid, so they may compete for the same monocarboxylic membrane carrier (Oldendorf, 1973; Poole and Halestrap, 1993) and therefore reduce the availability of the labeled substrate (acetate) to produce (14)CO2.”
Background
Permeability of the Blood-Brain Barrier to Circulating Free Fatty Acids
Banks, W. A., Kastin, A. J., & Rapoport, S. I. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2582-7_1 · Cited by 13
Is there a probenecid sensitive transport system for monoamine catabolites at the level of the brain capillary plexus?
Yuwiler, A., Bennett, B. L., & Geller, E. (1982) · Neurochemical Research · doi:10.1007/bf00965898 · Cited by 13
Commentary on: The aetiology of neurological complications of organic acidaemias—a role for the blood–brain barrier. Kölker S, Sauer SW, Surtees RAH, Leonard JV
Morris, A. A. M. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-9998-3 · Cited by 13
“Whereas methylmalonate is a DCA, propionate is a monocarboxylic acid and it is carried across the blood–brain barrier by the monocarboxylic acid transporter (MCT1) (Oldendorf 1973).”
Background
Blood-Brain Barrier: Techniques for the Intracerebral Administration of Drugs
MYERS, R. D. (1975) · Springer eBooks · doi:10.1007/978-1-4684-3168-1_1 · Cited by 13
Exploring environmental exposomes and the gut-brain nexus: Unveiling the impact of pesticide exposure
Khoo, S. C., Zhang, N., Luang‐In, V., Goh, M. S., Sonne, C., & Ling, N. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118441 · Cited by 13
Short-chain fatty acids profiling in biological samples from a mouse model of Sjögren’s syndrome based on derivatized LC-MS/MS assay
Nagatomo, R., Kaneko, H., Kamatsuki, S., Ichimura‐Shimizu, M., Ishimaru, N., Tsuneyama, K., & Inoue, K. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123432 · Cited by 14
Effect of In Vivo Administration of Ethylmalonic Acid on Energy Metabolism in Rat Tissues
Ferreira, G. C., André, K. R., Schuck, P. F., et al. (2006) · Metabolic Brain Disease · doi:10.1007/s11011-006-9004-7 · Cited by 12
“Furthermore, it is expected that EMA originated from butyryl-CoA produced in high amounts in the liver of these patients can penetrate into brain and other peripheral tissues since the transporter for short-chain fatty acids is an active carrier across tissues (Oldendorf, 1973), which is in accordance with our present…”
Result
The Use of Microdialysis for the Study of Drug Kinetics: Central Nervous System Pharmacokinetics of Diphenhydramine in Fetal, Newborn, and Adult Sheep
Au-Yeung, S. C. S., Riggs, K. W., Gruber, N., et al. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013995 · Cited by 12
“Many transporters are present at the BBB to deliver a range of substances into the CNS (Oldendorf, 1973), including sodium-independent organic cation transporters (Koepsell, 1998).”
Background
1-[11C]Pyruvate turnover in brain and muscle of patients with mitochondrial encephalomyopathy
Yokoi, F., Hara, T., Iio, M., et al. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90168-m · Cited by 12
The origin of free brain malonate
Riley, K. M., Dickson, A. C., & Koeppen, A. H. (1991) · Neurochemical Research · doi:10.1007/bf00965698 · Cited by 12
“Oldenorf (8) reported a similar barrier for other dicarboxylic acids.”
Background
Changes in the content and acyl group composition of glycerophospholipids of brain endothelial cells of the developing rat
Matheson, D. F., Oei, R., & Roots, B. I. (1980) · Neurochemical Research · doi:10.1007/bf00964707 · Cited by 12
Untersuchungen zur Genese und Biochemie der Pansenacidose
Giesecke, D., & Stangassinger, M. (2010) · Zentralblatt für Veterinärmedizin Reihe A · doi:10.1111/j.1439-0442.1979.tb00654.x · Cited by 12
Transport at the Blood–Brain Barrier
Neuhaus, W., & Noe, C. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627424.ch10 · Cited by 16
Neurochemical Aspects of Blood-Brain-Cerebrospinal Fluid Barriers
Cutler, R. W. P. (1980) · Springer eBooks · doi:10.1007/978-1-4684-1039-6_4 · Cited by 12
Hypophagia induced by endogenous or liposome-encapsulated 3,4-dihydroxybutanoic acid
Terada, K., Sakata, T., Oomura, Y., Fujimoto, K., Arase, K., Osanai, T., & Nagai, Y. (1986) · Physiology & Behavior · doi:10.1016/0031-9384(86)90055-7 · Cited by 12
Characteristics of lactate transfer in isolated cardiac myocytes
Kammermeier, H., WEIN, B. B., & Graf, W. D. (1984) · Steinkopff eBooks · doi:10.1007/978-3-662-11041-6_10 · Cited by 12
Bioenergetic adaptations to HIV infection. Could modulation of energy substrate utilization improve brain health in people living with HIV-1?
Deme, P., Rojas, C. J., Slusher, B. S., Rais, R., Afghah, Z., Geiger, J. D., & Haughey, N. J. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113181 · Cited by 10
“The primary MCT isoforms that are found in the brain include MCT1 that is expressed in endothelial cells of the blood brain barrier with some expression in astrocytes, and MCT2 that is primarily expressed in neurons (Oldendorf, 1973; Simpson et al., 2007).”
Background
Nanostructures Overcoming the Blood-Brain Barrier: Physiological Considerations and Mechanistic Issues
Lalatsa, A., Schätzlein, A. G., & Uchegbu, I. F. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735292-00329 · Cited by 12
Suppression of an ethanol withdrawal syndrome in rats by butyrate, lactate and β-hydroxybutyrate
Derr, R. F., Draves, K., & Derr, M. I. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90237-0 · Cited by 11
Untersuchungen zur Genese und Biochemie der Pansenacidose
Giesecke, D., & Stangassinger, M. (2010) · Zentralblatt für Veterinärmedizin Reihe A · doi:10.1111/j.1439-0442.1978.tb00932.x · Cited by 11
Memory processes and memory systems: Fractionation of human memory
Hijman, R. (1996) · Neuroscience Research Communications · doi:10.1002/(sici)1520-6769(199611)19:3 · Cited by 2
The role of acetate as a potential mediator of the effects of ethanol in the brain
Brundege, J. M., & Dunwiddie, T. V. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11320-v · Cited by 11
Metabolic preferences of astrocytes: Functional metabolic mapping reveals butyrate outcompetes acetate
Ameen, A. O., Nielsen, S. W., Kjær, M. W., Andersen, J. V., Westi, E. W., Freude, K., & Aldana, B. I. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241270457 · Cited by 13
“57 When cerebral cortical slices and cultured astrocytes were incubated with [1,2-13 C]acetate and unlabelled 12 C-butyrate, a reduction in 13 C enrichment of a majority of the TCA metabolites occurred.”
A novel set of volatile urinary biomarkers for late-life major depressive and anxiety disorders upon the progression of frailty: a pilot study
Fujita, A., Ihara, K., Kawai, H., Obuchi, S. P., Watanabe, Y., Hirano, H., Fujiwara, Y., Takeda, Y., Tanaka, M., & Kato, K. (2022) · Discover Mental Health · doi:10.1007/s44192-022-00023-0 · Cited by 10
“SCFAs can cross the blood–brain barrier and are found in human CSF [77].”
Background
Different effects of monocarboxylates on neuronal survival and β‐amyloid toxicity
Wang, X., Takata, T., Sakurai, T., & Yokono, K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05853.x · Cited by 10
“In addition, as pyruvate can cross the blood–brain barrier (Oldendorf, 1973), it could be of therapeutic value in pathological situations such as ischemiareperfusion or trauma, in which the acute production of free radicals is believed to play a critical role (Desagher et al., 1997).”
Background
Synaptic Plasma Membrane Na+, K+-ATPase Activity is Significantly Reduced by the α-Keto Acids Accumulating in Maple Syrup Urine Disease in Rat Cerebral Cortex
Wajner, A., Bürger, C., Dutra‐Filho, C. S., et al. (2007) · Metabolic Brain Disease · doi:10.1007/s11011-007-9046-5 · Cited by 10
“In this scenario, transport of branched-chain amino acids and keto acids into brain through the blood-brain barrier seems to be effective and quick (Oldendorf, 1973; Steele, 1986).”
Background
Computer modeling of blood brain barrier permeability for physiologically active compounds
Raevsky, O. A., Solodova, S. L., Lagunin, A. A., et al. (2013) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s199075081302008x · Cited by 10
The ethanol withdrawal syndrome: A consequence of lack of substrate for a cerebral Krebs-cycle
Derr, R. F. (1984) · Journal of Theoretical Biology · doi:10.1016/0022-5193(84)90036-5 · Cited by 10
The Physiological Function of the Blood-Brain Barrier Transporters as the CNS Supporting and Protecting System
Ohtsuki, S. (2004) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.124.791 · Cited by 10
Effects of hypoxia on rat brain metabolism: Unilateral in vivo carotid infusion
Рапопорт, С. И., Lust, W. D., & Fredericks, W. R. (1986) · Experimental Neurology · doi:10.1016/0014-4886(86)90072-5 · Cited by 10
Studies of cerebral β-hydroxybutyrate transport by carotid injection; effects of age, diet and injectant composition
Regen, D. M., Callis, J. T., & Sugden, M. C. (1983) · Brain Research · doi:10.1016/0006-8993(83)90291-3 · Cited by 10
Glucose is required to maintain ATP/ADP ratio of isolated bovine cerebral microvessels
Gaposchkin, C. G., Tornheim, K., Sussman, I., et al. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.3.e543 · Cited by 10
Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study
Al-Akl, N. S., Khalifa, O., Ponirakis, G., Parray, A., Ramadan, M., Khan, S., Chandran, M., Ayadathil, R., Elsotouhy, A., Own, A. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042247 · Cited by 9
“AKG can enter the brain through different mechanisms, including carrier-mediated processes, simple diffusion, and transport across mitochondrial membranes [53,54].”
Background
Metabolic Dysfunctions in Epilepsy and Novel Metabolic Treatment Approaches
Tan, K. N., McDonald, T. S., & Borges, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411462-3.00048-5 · Cited by 11
Drug delivery via active transport at the blood-brain barrier: II. Investigation of monocarboxylic acid transport in vitro
Walker, I., Nicholls, D., Irwin, W. J., et al. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90131-7 · Cited by 9
[1-11C]Octanoate as a potential PET tracer for studying glial functions: PET evaluation in rats and cats
Kuge, Y., Kawashima, H., Yamazaki, S., et al. (1996) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(96)00148-5 · Cited by 9
The Influence of Liver-Bypass on Transport and Compartmentation In Vivo
Cremer, J. E. (1976) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-3264-0_8 · Cited by 9
COVID-19-associated encephalopathy: connection between neuroinflammation and microbiota-gut-brain axis
Duve, K. V., Petakh, P., & Kamyshnyi, O. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1406874 · Cited by 11
“The increased expression of monocarboxylate transporters (MCTs) in endothelial cells could facilitate the passage of SCFAs across the BBB, as evidenced by studies administering labeled SCFAs directly into the carotid artery of rats (Oldendorf, 1973; Vijay and Morris, 2014).”
Background
Neuronal Energy Requirements
Schurr, A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-108-4_2 · Cited by 8
Brain ischemia and infarction positively visualized by pyruvate-1-11C using positron-emission tomography
Hara, T., Yokoi, F., & Iio, M. (1986) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00638790 · Cited by 8
“Pyruvate is supplied to brain cells either as the end-product of intracellular glycolysis or by direct penetration from the blood across the blood-brain barrier (Oldendorf 1973), although the contribution of the latter is comparatively small in physiological terms (Pardridge and Oldendorf 1977).”
Background
Effect of Probenecid on Cerebral and Cisternal Cerebrospinal Fluid Lactate Content
MacMillan, V. (1987) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1987.17 · Cited by 8
“…could have been ex pected from previous studies that showed an inhibi tory effect of probenecid on endothelial monocar boxylic acid transport (Pardridge et al., 1975; Yu wiler et aI., 1982) and from the suggestion that lactate shares with probenecid and 5-HIAA a common saturable carrier from…”
Result
8-[18F]fluorooctanoic acid and its β-substituted derivatives as potential agents for cerebral fatty acid studies: Synthesis and biodistribution
Nagatsugi, F., Sasaki, S., & Maëda, M. (1994) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(94)90160-0 · Cited by 8
Preferential accumulation of 11C in human brain tumors after intravenous injection of 11C-1-pyruvate
Tsukiyama, T., Hara, T., Iio, M., et al. (1986) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00251978 · Cited by 8
Uptake of radioactive octanoate in astrocytoma cells: Basic studies for application of [11C]octanoate as a PET tracer
Yamazaki, S., Fukui, K., Kawashima, H., Kuge, Y., Miyake, Y., & Kangawa, K. (1996) · Annals of Nuclear Medicine · doi:10.1007/bf03164800 · Cited by 8
Evaluation of the brain uptake properties of [1-11C]labeled hexanoate in anesthetized cats by means of positron emission tomography
Sakiyama, Y., Ishiwata, K., Ishii, K., et al. (1996) · Annals of Nuclear Medicine · doi:10.1007/bf03164748 · Cited by 8
Blood‐brain barrier permeability during shortlasting intravascular hyperosmolality
Paulson, O. B., & Hertz, M. M. (1978) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1978.tb00870.x · Cited by 8
Ethanol and the Blood-Brain Barrier
Chin, J. H. (1979) · Springer eBooks · doi:10.1007/978-1-4684-3450-7_7 · Cited by 8
Transport of Hexoses and Monocarboxylic Acids
BACHELARD, H. S. (1983) · Springer eBooks · doi:10.1007/978-1-4899-4555-6_16 · Cited by 8
The role of nutrition in canine idiopathic epilepsy management: Fact or fiction?
Verdoodt, F., Watanangura, A., Bhatti, S. F. M., Schmidt, T., Suchodolski, J. S., Ham, L. V., Meller, S., Volk, H. A., & Hesta, M. (2022) · The Veterinary Journal · doi:10.1016/j.tvjl.2022.105917 · Cited by 8
Preliminary evaluation of [1-11C]octanoate as a PET tracer for studying cerebral ischemia: A PET study in rat and canine models of focal cerebral ischemia
Kuge, Y., Kawashima, H., Hashimoto, T., Imanishi, M., Shiomi, M., Minematsu, K., Hasegawa, Y., Yamaguchi, T., Miyake, Y., & Hashimoto, N. (2000) · Annals of Nuclear Medicine · doi:10.1007/bf02990482 · Cited by 7
In vitro uptake of [1-14C]Octanoate in brain slices of rats: basic studies for assessing [1-11C]Octanoate as a PET tracer of glial functions.
Kuge, Y., Hikosaka, K., Seki, K., Ohkura, K., Nishijima, K., Tsukamoto, E., & Tamaki, N. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(01)00309-2 · Cited by 8
A brain uptake study of [1-11C]hexanoate in the mouse: The effect of hypoxia, starvation and substrate competition
Ishiwata, K., Ishii, K., Ogawa, K., et al. (1996) · Annals of Nuclear Medicine · doi:10.1007/bf03165404 · Cited by 7
Capric acid
(1979) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(79)80017-6 · Cited by 7
Transport und Entgiftung: Grundlagen, Ansätze und Perspektiven für die Erforschung der Blut‐Hirn‐Schranke
Aigner, A. M., Wolf, S., & Gassen, H. G. (1997) · Angewandte Chemie · doi:10.1002/ange.19971090105 · Cited by 7
Fusobacterium nucleatum enhances amphetamine-induced behavioral responses through a butyrate-driven epigenetic mechanism
Mabry, S. J., Cao, X., Zhu, Y., Rowe, C., Patel, S., González‐Arancibia, C., Romanazzi, T., Saleeby, D. P., Elam, A., Lee, H.-T., et al. (2025) · Science Signaling · doi:10.1126/scisignal.adx7729 · Cited by 7
The role of gut-derived short-chain fatty acids in Parkinson's disease
Saadh, M. J., Mustafa, A. N., Mustafa, M. A., Renuka Jyothi, S., Dabis, H. K., Prasad, G. V. S., Mohammad, I. J., Adnan, A., & Idan, A. H. (2024) · Neurogenetics · doi:10.1007/s10048-024-00779-3 · Cited by 9
“In preclinical PD models, SCFAs have demonstrated the ability to traverse the BBB, facilitating direct interactions with brain cells [333].”
Oral Administration of Bifidobacterium lactis Ameliorates Cognitive Deficits in Mice Intracerebroventricularly Administered Amyloid Beta via Regulation the Activation of Mitogen-activated Protein Kinases
Choi, J. K., Kwon, O. Y., & Lee, S. H. (2024) · Food Science of Animal Resources · doi:10.5851/kosfa.2024.e5 · Cited by 7
“In addition, studies have shown that SCFAs produced by the gut microbiota move into the bloodstream and finally reach the brain by penetrating the blood-brain barrier (Kekuda et al., 2013; Oldendorf, 1973).”
Background
Prevention of Neurologic Disease with Fasting
Macri, E., & Azhar, Y. (2022) · Seminars in Neurology · doi:10.1055/a-1957-8449 · Cited by 6
Coupling of Blood Flow to Neuronal Excitability
GJEDDE, A. H. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-108-4_9 · Cited by 6
Blood—brain barrier amino-acid transport: clinical implications
Pardridge, W. M. (1982) · Springer eBooks · doi:10.1007/978-94-009-7325-1_6 · Cited by 6
Brain uptake of halogenated products of D-glucal
Homma, Y., Murase, Y., & Ishii, M. (1983) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/bf02517592 · Cited by 6
Structural characteristics of endogenous sugar acids and relations to feeding modulation
Sakata, T., Arase, K., Fujimoto, K., et al. (1988) · Brain Research · doi:10.1016/0006-8993(88)90313-7 · Cited by 6
Modeling the Route of Administration-Based Enhancement in the Brain Delivery of EAB 515, Studied by Microdialysis
Malhotra, B. K., Brundage, R. C., Lemaire, M., & Sawchuk, R. J. (1997) · Journal of drug targeting · doi:10.3109/10611869708995843 · Cited by 6
Short-Chain Fatty Acid Profiles in Amyotrophic Lateral Sclerosis: Longitudinal Effects of Disease and Mediterranean Diet Intervention
Moțățăianu, A., Ion, V., Dumitreasă, M., Ormenișan, I., Farczádi, L., Andone, S. R., Bălașa, R., & Roman, M. (2025) · Biomolecules · doi:10.3390/biom15101380 · Cited by 7
Positron emission tomographical studies of 1-11C-acetoacetate, 2-18F-fluoro-deoxy-D-glucose, and L-1-11C-tyrosine uptake by cat brain with an experimental lesion
Prenen, G. H. M., Go, K. G., Paans, A. M. J., et al. (1989) · Acta Neurochirurgica · doi:10.1007/bf01402328 · Cited by 5
Characteristic brain distribution of 1-(14)C-octanoate in a rat model of focal cerebral ischemia in comparison with those of (123)I-IMP and (123)I-iomazenil.
Kuge, Y., Hikosaka, K., Seki, K., Ohkura, K., Nishijima, K.-C., Kaji, T., Ueno, S., Tsukamoto, E., & Tamaki, N. (2003) · PubMed · Cited by 5
COMPARISON OF METHODS FOR DETERMINING BLOOD-BRAIN BARRIER PERMEABILITY
Patlak, C. S., & Fenstermacher, J. D. (1975) · Elsevier eBooks · doi:10.1016/b978-0-12-197450-3.50008-4 · Cited by 5
History and Basic Concepts
Davson, H., Zloković, B. V., Rakić, L., & Segal, M. B. (1993) · doi:10.1007/978-1-349-11882-3_1 · Cited by 6
Single-Pass Dual-Label Indicator Method: Blood-to-Brain Transport of Glucose and Short-Chain Monocarboxylic Acids
Puchowicz, M. A., Xu, K., & LaManna, J. C. (2003) · Humana Press eBooks · doi:10.1385/1-59259-419-0:265 · Cited by 5
Development of the Blood-Brain Barrier
Laterra, J., & Goldstein, G. W. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7216-9654-6.50169-7 · Cited by 5
Non-Anticoagulant Actions of Glycosaminoglycans (GAGs)
Cornelli, U. (1996) · Springer eBooks · doi:10.1007/978-1-4613-0371-8_20 · Cited by 5
Short-chain fatty acids
Dagbasi, A., Cai, M., Hirdaramani, A., Hanyaloglu, A. C., Morrison, D. J., & Frost, G. S. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01579-9 · Cited by 6
“Acetate and propionate can cross the blood–brain barrier through monocarboxylate transporters, reaching micromolar concentrations in brain tissue 185,186 .”
Interplay of alpha-synuclein pathology and gut microbiome in Parkinson’s disease
Srivastava, A., Kataria, A., Yadav, D. K., Han, I., & Choi, E. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91313-3.00003-9 · Cited by 4
Neurodevelopment and the gut microbiome
Oliphant, K., & Lu, J. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820602-7.00006-4 · Cited by 6
Automated production of [11C]butyrate for keto body PET imaging
Pakula, R. J., Raffel, D. M., Koeppe, R. A., et al. (2023) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2023.108315 · Cited by 4
Entry and Deposit of Aluminum in the Brain
Wang, L. (2023) · Springer eBooks · doi:10.1007/978-981-99-1592-7_3 · Cited by 4
Metabolic Interactions between Neurons and Glial Cells
Poitry‐Yamate, C., & Pournaras, C. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-05714-1.00012-1 · Cited by 4
Transport of α-Ketoisocaproate in Neuroblastoma NB-2a Cells
Bachowska-Mac, M., Nehlig, A., ȩ, M. J. N., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7001 · Cited by 4
Potential link of high fat diet and mRNA expression of Alzheimer's disease-related genes in the enteric mucosa of a rat model of Alzheimer's disease
Gokulan, K., Karn, K., Sarkar, S., Raymick, J. B., & Khare, S. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251358414 · Cited by 3
“38 Interestingly, in the HFD-fed WT males and TG females, the FR of plg was signi ﬁ cantly higher along with several other AD-related genes; implicating a potential role for plasminogen in the gut-brain axis.”
Microbiome functional gene pathways are indicative of cognitive performance in older adults at risk for Alzheimer's disease
Zeamer, A. L., Lai, Y., Loew, E. B., Sanborn, V. E., Tracy, M., Jo, C., Ferdinand, D., Ward, D. V., Bhattarai, S. K., Drake, J., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2676162 · Cited by 6
Neurosteroids, Microbiota, and Neuroinflammation: Mechanistic Insights and Therapeutic Perspectives
Tahri, A., Niccolai, E., & Amedei, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26147023 · Cited by 3
“In addition to their metabolic functions, SCFAs are involved in the regulation of inflammatory pathways and neuroinflammation [142–144].”
Processus de transport à travers la barrière hémato-encéphalique
Lefauconnier, J.-M. (1989) · annales de biologie animale biochimie biophysique · doi:10.1051/rnd:19890608 · Cited by 3
Short-Chain Fatty Acids-A Healthy Bus between Gut Microbiota and Organs beyond the Gut
Cao, R., Zeng, Y., Li, S., Xue, P., & Li, M. (2022) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2022.139024 · Cited by 3
Salts of Short-Chain Fatty Acids Increase the Activity of Large Conductance Ca2+-Activated K+ Channels and Decrease Calcium Oscillations in Rat GH3 Cells
Shaidullov, I. F., Ermakova, E. V., Sorokina, D. M., Yakovleva, O. V., & Ситдикова, Г. Ф. (2023) · BIOPHYSICS · doi:10.1134/s0006350923040188 · Cited by 3
Structural and stereoisomeric specificity of serum-borne sugar acids related to feeding control by rats
Sakata, T. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90196-7 · Cited by 3
Neuroprotective Mechanisms: Oxidative Stress as a Target for Neuroprotective Therapies in Alzheimer's and Parkinson's Disease
Huber, A., Bürkle, A., & Münch, G. W. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_6 · Cited by 3
Treatment of Eye Infections
Miller, M. H., & Mayers, M. (2014) · ASM Press eBooks · doi:10.1128/9781555817817.ch18 · Cited by 3
Secretin and vasoactive intestinal peptide inhibit fluid absorption and induce secretion in the isolated gall-bladder of the guinea-pig [proceedings].
Morton, I. K., Phillips, S. J., Saverymuttu, S. H., et al. (1977) · PubMed · Cited by 3
Nanomedicines for Delivery Across the Blood–Brain Barrier
Lalatsa, A., Das, D., & Osouli-Bostanabad, K. (2024) · Springer eBooks · doi:10.1007/978-3-031-59478-6_11 · Cited by 2
Associations of diet-derived short chain fatty acids with Parkinson’s disease: a systematic review and meta-analysis
An, K., Qu, Y., Li, J., Wang, D., Mao, Z., & Xue, Z. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2558119 · Cited by 2
“But according to Oldendorf et al. [54], SCFAs could cross the blood–brain barrier (BBB) and enter the cephalic regions.”
1‐Kestose Prevents Psychiatric‐Like Behavior by Enhancing Short‐Chain Fatty Acid Production
Tanabe, M., Kunisawa, K., Fujii, T., Tochio, T., Hirooka, Y., Ojika, H., Naruoka, Y., Ito, H., Saito, K., Nabeshima, T., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70273 · Cited by 2
“SCFA can cross the blood–brain barrier and have been reported to suppress microglial activation, a key contributor to neuroin-flammation (Oldendorf 1973; Erny et al. 2015).”

Authors: Oldendorf, W.
Corresponding author: Oldendorf, WH
Venue: American Journal of Physiology-Legacy Content
Publisher: American Physiological Society
Published: 1973-06-01
Volume: 224
Issue: 6
Pages: 1450-1453
ISSN: 0002-9513 (ISSN-L)
DOI: 10.1152/ajplegacy.1973.224.6.1450
OpenAlex: W2294335852
Cited by: 463
References: 0
Citations by year: 2026: 16 · 2025: 17 · 2024: 21 · 2023: 20 · 2022: 32 · 2021: 13 · 2020: 7 · 2019: 5 · 2018: 9 · 2017: 2 · 2016: 9 · 2015: 4 · 2014: 4 · 2013: 9 · 2012: 6
FWCI: 4.23
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Physiology-Legacy Content (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords: blood-brain barrier, carrier-mediated transport, organic acids, brain uptake, monocarboxylate transporters
MeSH terms: Acetates, Amino Acids, Animals, Biological Transport, Blood-Brain Barrier, Brain, Butyrates, Carbon Isotopes, Carboxylic Acids, Dicarboxylic Acids, Female, Glucose, Lactates, Male, Propionates, Pyruvates, Tricarboxylic Acids, Tritium, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks